125 related articles for article (PubMed ID: 17662312)
21. Interleukin-8 induces the endothelial cell migration through the Rac 1/RhoA-p38MAPK pathway.
Lai Y; Liu XH; Zeng Y; Zhang Y; Shen Y; Liu Y
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):630-8. PubMed ID: 22774404
[TBL] [Abstract][Full Text] [Related]
22. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
Lepley D; Paik JH; Hla T; Ferrer F
Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375
[TBL] [Abstract][Full Text] [Related]
23. Binding of Dickkopf-3 to CXCR7 Enhances Vascular Progenitor Cell Migration and Degradable Graft Regeneration.
Issa Bhaloo S; Wu Y; Le Bras A; Yu B; Gu W; Xie Y; Deng J; Wang Z; Zhang Z; Kong D; Hu Y; Qu A; Zhao Q; Xu Q
Circ Res; 2018 Aug; 123(4):451-466. PubMed ID: 29980568
[TBL] [Abstract][Full Text] [Related]
24. Integrin α6β4 cooperates with LPA signaling to stimulate Rac through AKAP-Lbc-mediated RhoA activation.
O'Connor KL; Chen M; Towers LN
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C605-14. PubMed ID: 22049212
[TBL] [Abstract][Full Text] [Related]
25. TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production.
Lee GL; Chang YW; Wu JY; Wu ML; Wu KK; Yet SF; Kuo CC
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2751-60. PubMed ID: 22995520
[TBL] [Abstract][Full Text] [Related]
26. GIT1 mediates thrombin signaling in endothelial cells: role in turnover of RhoA-type focal adhesions.
van Nieuw Amerongen GP; Natarajan K; Yin G; Hoefen RJ; Osawa M; Haendeler J; Ridley AJ; Fujiwara K; van Hinsbergh VW; Berk BC
Circ Res; 2004 Apr; 94(8):1041-9. PubMed ID: 15016733
[TBL] [Abstract][Full Text] [Related]
27. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.
Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG
Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609
[TBL] [Abstract][Full Text] [Related]
29. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells.
Marinkovic G; Hibender S; Hoogenboezem M; van Broekhoven A; Girigorie AF; Bleeker N; Hamers AA; Stap J; van Buul JD; de Vries CJ; de Waard V
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2380-8. PubMed ID: 23950142
[TBL] [Abstract][Full Text] [Related]
31. Inhibiting RHOA Signaling in Mice Increases Glucose Tolerance and Numbers of Enteroendocrine and Other Secretory Cells in the Intestine.
Petersen N; Frimurer TM; Terndrup Pedersen M; Egerod KL; Wewer Albrechtsen NJ; Holst JJ; Grapin-Botton A; Jensen KB; Schwartz TW
Gastroenterology; 2018 Oct; 155(4):1164-1176.e2. PubMed ID: 29935151
[TBL] [Abstract][Full Text] [Related]
32. Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms.
Birukova AA; Smurova K; Birukov KG; Usatyuk P; Liu F; Kaibuchi K; Ricks-Cord A; Natarajan V; Alieva I; Garcia JG; Verin AD
J Cell Physiol; 2004 Oct; 201(1):55-70. PubMed ID: 15281089
[TBL] [Abstract][Full Text] [Related]
33. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis.
Del Galdo S; Vettel C; Heringdorf DM; Wieland T
Cell Signal; 2013 Dec; 25(12):2478-84. PubMed ID: 23993968
[TBL] [Abstract][Full Text] [Related]
34. Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) affects RhoA activation in endothelial cells.
Suzuki T; Abe M; Miyashita H; Kobayashi T; Sato Y
J Cell Physiol; 2007 Jun; 211(3):708-15. PubMed ID: 17385722
[TBL] [Abstract][Full Text] [Related]
35. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN.
Sanchez T; Skoura A; Wu MT; Casserly B; Harrington EO; Hla T
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1312-8. PubMed ID: 17431187
[TBL] [Abstract][Full Text] [Related]
36. RhoA and Rac mediate endothelial cell polarization and detachment induced by T-cadherin.
Philippova M; Ivanov D; Allenspach R; Takuwa Y; Erne P; Resink T
FASEB J; 2005 Apr; 19(6):588-90. PubMed ID: 15703273
[TBL] [Abstract][Full Text] [Related]
37. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists.
Erin N; Nizam E; Tanrıöver G; Köksoy S
Breast Cancer Res Treat; 2015 Feb; 150(1):57-69. PubMed ID: 25682075
[TBL] [Abstract][Full Text] [Related]
38. Conditional deletion of FAK in mice endothelium disrupts lung vascular barrier function due to destabilization of RhoA and Rac1 activities.
Schmidt TT; Tauseef M; Yue L; Bonini MG; Gothert J; Shen TL; Guan JL; Predescu S; Sadikot R; Mehta D
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L291-300. PubMed ID: 23771883
[TBL] [Abstract][Full Text] [Related]
39. RhoA and Rac1 play independent roles in lysophosphatidic acid-induced ovarian cancer chemotaxis.
Hwang H; Kim EK; Park J; Suh PG; Cho YK
Integr Biol (Camb); 2014 Mar; 6(3):267-76. PubMed ID: 24469268
[TBL] [Abstract][Full Text] [Related]
40. Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice.
Nuno DW; Harrod JS; Lamping KG
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1469-77. PubMed ID: 19666843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
